Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2005 Jun;42(6):485–490. doi: 10.1136/jmg.2004.025734

VEGF polymorphisms and severity of atherosclerosis

W Howell 1, S Ali 1, M Rose-Zerilli 1, S Ye 1
PMCID: PMC1736081  PMID: 15937083

Abstract

Introduction: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor, and neovascularisation has been shown to be important in atherosclerotic plaque development. There is some disagreement as to whether VEGF acts as a pro-atherosclerotic or anti-atherosclerotic factor. In the present study we have sought to clarify this by determining genotypes and haplotypes for three reportedly functional VEGF SNPs in a large series of well documented coronary atherosclerosis patients.

Methods: VEGF –2578, –1154, and –634 single nucleotide polymorphisms were genotyped in 984 subjects from the Southampton Atherosclerosis Study, using the 5' nuclease assay for allelic discrimination (TaqMan).

Results: VEGF –2578 genotypes showed a significantly different distribution in patients without myocardial infarction when stratified according to number of diseased arteries. VEGF –2578 was also associated with mean number of stenotic segments in the same patient group. The AA genotype was a risk factor and CC was protective. These associations were significant before and after adjustment for classic risk factors, and were reflected in associations between VEGF haplotypes and the number of diseased arteries and stenotic segments. As VEGF –2578 CC has been provisionally shown to be associated with higher VEGF expression than the AA genotype, these results are consistent with a protective effect for VEGF in atherosclerosis development. Some changes in VEGF –1154 genotype frequencies were also detected, but no significant associations were detected for any one particular genotype.

Conclusions: This study provides preliminary evidence that VEGF polymorphism is associated with development of atherosclerosis, possibly via regulation of VEGF expression, supporting a protective effect for VEGF in atherosclerosis. These results require replication in an independent study group, combined with study of additional candidate polymorphisms in the VEGF gene.

Full Text

The Full Text of this article is available as a PDF (83.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asahara T., Bauters C., Pastore C., Kearney M., Rossow S., Bunting S., Ferrara N., Symes J. F., Isner J. M. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995 Jun 1;91(11):2793–2801. doi: 10.1161/01.cir.91.11.2793. [DOI] [PubMed] [Google Scholar]
  2. Asahara T., Chen D., Tsurumi Y., Kearney M., Rossow S., Passeri J., Symes J. F., Isner J. M. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation. 1996 Dec 15;94(12):3291–3302. doi: 10.1161/01.cir.94.12.3291. [DOI] [PubMed] [Google Scholar]
  3. Awata Takuya, Inoue Kiyoaki, Kurihara Susumu, Ohkubo Tomoko, Watanabe Masaki, Inukai Kouichi, Inoue Ikuo, Katayama Shigehiro. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002 May;51(5):1635–1639. doi: 10.2337/diabetes.51.5.1635. [DOI] [PubMed] [Google Scholar]
  4. Barleon B., Sozzani S., Zhou D., Weich H. A., Mantovani A., Marmé D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 1996 Apr 15;87(8):3336–3343. [PubMed] [Google Scholar]
  5. Brogan I. J., Khan N., Isaac K., Hutchinson J. A., Pravica V., Hutchinson I. V. Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum Immunol. 1999 Dec;60(12):1245–1249. doi: 10.1016/s0198-8859(99)00132-9. [DOI] [PubMed] [Google Scholar]
  6. Celletti F. L., Waugh J. M., Amabile P. G., Brendolan A., Hilfiker P. R., Dake M. D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med. 2001 Apr;7(4):425–429. doi: 10.1038/86490. [DOI] [PubMed] [Google Scholar]
  7. Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P. C., Pan Y. C., Olander J. V., Connolly D. T., Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990 Dec 1;172(6):1535–1545. doi: 10.1084/jem.172.6.1535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grosskreutz C. L., Anand-Apte B., Dupláa C., Quinn T. P., Terman B. I., Zetter B., D'Amore P. A. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res. 1999 Sep;58(2):128–136. doi: 10.1006/mvre.1999.2171. [DOI] [PubMed] [Google Scholar]
  9. Howell W. M., Bateman A. C., Turner S. J., Collins A., Theaker J. M. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun. 2002 Jun;3(4):229–232. doi: 10.1038/sj.gene.6363851. [DOI] [PubMed] [Google Scholar]
  10. Krippl Peter, Langsenlehner Uwe, Renner Wilfried, Yazdani-Biuki Babak, Wolf Gerald, Wascher Thomas C., Paulweber Bernhard, Haas Josef, Samonigg Hellmut. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer. 2003 Sep 10;106(4):468–471. doi: 10.1002/ijc.11238. [DOI] [PubMed] [Google Scholar]
  11. Lambrechts Diether, Storkebaum Erik, Morimoto Masafumi, Del-Favero Jurgen, Desmet Frederik, Marklund Stefan L., Wyns Sabine, Thijs Vincent, Andersson Jörgen, van Marion Ingrid. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003 Aug;34(4):383–394. doi: 10.1038/ng1211. [DOI] [PubMed] [Google Scholar]
  12. Lemström Karl B., Krebs Rainer, Nykänen Antti I., Tikkanen Jussi M., Sihvola Roope K., Aaltola Eva M., Häyry Pekka J., Wood Jeanette, Alitalo Kari, Ylä-Herttuala Seppo. Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation. 2002 May 28;105(21):2524–2530. doi: 10.1161/01.cir.0000016821.76177.d2. [DOI] [PubMed] [Google Scholar]
  13. Moulton Karen S., Vakili Khashayar, Zurakowski David, Soliman Mohsin, Butterfield Catherine, Sylvin Erik, Lo Kin-Ming, Gillies Stephen, Javaherian Kashi, Folkman Judah. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A. 2003 Apr 7;100(8):4736–4741. doi: 10.1073/pnas.0730843100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ray David, Mishra Manoj, Ralph Shirley, Read Ian, Davies Robert, Brenchley Paul. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes. 2004 Mar;53(3):861–864. doi: 10.2337/diabetes.53.3.861. [DOI] [PubMed] [Google Scholar]
  15. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000 Nov-Dec;37(6):443–448. doi: 10.1159/000054076. [DOI] [PubMed] [Google Scholar]
  16. Shahbazi Majid, Fryer Anthony A., Pravica Vera, Brogan Iain J., Ramsay Helen M., Hutchinson Ian V., Harden Paul N. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol. 2002 Jan;13(1):260–264. doi: 10.1681/ASN.V131260. [DOI] [PubMed] [Google Scholar]
  17. Shen H., Clauss M., Ryan J., Schmidt A. M., Tijburg P., Borden L., Connolly D., Stern D., Kao J. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood. 1993 May 15;81(10):2767–2773. [PubMed] [Google Scholar]
  18. Stary H. C., Chandler A. B., Dinsmore R. E., Fuster V., Glagov S., Insull W., Jr, Rosenfeld M. E., Schwartz C. J., Wagner W. D., Wissler R. W. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995 Sep 1;92(5):1355–1374. doi: 10.1161/01.cir.92.5.1355. [DOI] [PubMed] [Google Scholar]
  19. Stevens Adam, Soden Joanne, Brenchley Paul E., Ralph Shirley, Ray David W. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res. 2003 Feb 15;63(4):812–816. [PubMed] [Google Scholar]
  20. Tsurumi Y., Murohara T., Krasinski K., Chen D., Witzenbichler B., Kearney M., Couffinhal T., Isner J. M. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med. 1997 Aug;3(8):879–886. doi: 10.1038/nm0897-879. [DOI] [PubMed] [Google Scholar]
  21. Van Belle E., Maillard L., Tio F. O., Isner J. M. Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation. Biochem Biophys Res Commun. 1997 Jun 18;235(2):311–316. doi: 10.1006/bbrc.1997.6772. [DOI] [PubMed] [Google Scholar]
  22. Van Belle E., Tio F. O., Chen D., Maillard L., Chen D., Kearney M., Isner J. M. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol. 1997 May;29(6):1371–1379. doi: 10.1016/s0735-1097(97)00049-1. [DOI] [PubMed] [Google Scholar]
  23. Van Belle E., Tio F. O., Couffinhal T., Maillard L., Passeri J., Isner J. M. Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation. 1997 Jan 21;95(2):438–448. doi: 10.1161/01.cir.95.2.438. [DOI] [PubMed] [Google Scholar]
  24. Watson C. J., Webb N. J., Bottomley M. J., Brenchley P. E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 2000 Aug;12(8):1232–1235. doi: 10.1006/cyto.2000.0692. [DOI] [PubMed] [Google Scholar]
  25. Ye Shu, Dunleavey Louise, Bannister Wendy, Day Lorna B., Tapper William, Collins Andrew R., Day Ian N. M., Simpson Iain, Southampton Atherosclerosis Study Independent effects of the -219 G>T and epsilon 2/ epsilon 3/ epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study. Eur J Hum Genet. 2003 Jun;11(6):437–443. doi: 10.1038/sj.ejhg.5200983. [DOI] [PubMed] [Google Scholar]
  26. Zhao Qingwei, Egashira Kensuke, Inoue Shujiro, Usui Makoto, Kitamoto Shiro, Ni Weihua, Ishibashi Minako, Hiasa Ki Ken-ichi, Ichiki Toshihiro, Shibuya Masabumi. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation. 2002 Mar 5;105(9):1110–1115. doi: 10.1161/hc0902.104718. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES